## Abstract We report the molecular characterization of 38 new Kaposi's sarcoma‐associated herpesvirus (KSHV) strains from Russian patients with either classic (25 cases), epidemic/AIDS‐associated (7 cases), or posttransplant/immunosuppressed patients (6 cases), or Kaposi's sarcoma (KS). While a co
Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients
✍ Scribed by Abeltje M. Polstra; Jaap Goudsmit; Marion Cornelissen
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 62 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Human herpes virus 8 (HHV‐8) is associated with all clinical forms of Kaposi's sarcoma. HHV‐8 DNA is present in Kaposi's sarcoma biopsies and is observed regularly in saliva and less consistently in blood of Kaposi's sarcoma patients. The expression pattern of latent (ORF 73) and lytic (vGCR, vBcl‐2, and vIL‐6) HHV‐8 mRNA was studied in peripheral blood mononuclear cell (PBMC) samples and Kaposi's sarcoma skin biopsies from 11 AIDS Kaposi's sarcoma patients with four different nucleic acid sequence‐based amplification (NASBA) assays. Patients were divided into groups according to the clinical stage of Kaposi's sarcoma (stage I–IV). All biopsies were positive for two or more of the mRNA measured. No clear difference could be seen in the expression pattern in the lesions of the different clinical stages. In the corresponding PBMC samples, very little or no mRNA was measurable in the patients with Kaposi's sarcoma stage I or II, whereas patients with more advanced Kaposi's sarcoma (stage III or IV) had more detectable mRNA in the PBMCs. Thus, the HHV‐8 DNA load in the PBMCs increases in more advanced Kaposi's sarcoma, as does the frequency of mRNA detection in PBMCs. J. Med. Virol. 70:624–627, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract In AIDS/Kaposi's sarcoma (KS) patients, the sensitivity of immunofluorescence assays for detecting antibodies against latent nuclear antigen ranges from 52% to 93%. However, in classic and African KS, sensitivities above 90% have been reported systematically. This study evaluates whethe
## Abstract The patterns of antibodies against latent and lytic antigens of human herpesvirus 8 (HHV‐8) were assessed using immunofluorescence assays of samples from 155 persons seropositive for HHV‐8 seen at public health centers and 24 patients with Kaposi's sarcoma (KS) from Mozambique. Of the 1
Analysis by polymerase chain reaction (PCR) and serological studies have demonstrated a close association between the novel human herpes virus, Kaposi's sarcoma-associated herpes virus (KSHV) or human herpes virus-8 (HHV-8) and the development of Kaposi's sarcoma (KS). To clarify the role of HHV-8 i
## Abstract Differences in the prevalence of human herpesvirus 8 (HHV‐8) and Kaposi's sarcoma (KS) have been described, depending on the study population and their geographic origin. A cross‐ sectional study aimed at detecting the frequency and titers of antibodies against HHV‐8 latent and lytic an